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In chronic pancreatitis (CP) a benign inﬂammatory process in the pancreas results in progressive
structural changes with replacement of functional exocrine and endocrine parenchyma by a ﬁbrotic and
inﬂammatory tissue, often evident as an inﬂammatory mass. The consequences are diabetes mellitus,
exocrine insufﬁciency, and severe recurrent upper abdominal pain, often resulting in a signiﬁcant
reduction in the quality of life. The inﬂammatory process or the formation of pseudocysts can cause local
complications such as obstruction of the pancreatic duct, bile duct or the duodenum. In spite of intensive
research there is still no speciﬁc therapy for CP. Medical pharmacologic treatment is the basis of therapy
in CP and aims at pain relief and treatment of exocrine and endocrine insufﬁciency. However, many
patients require additional therapy for effective pain relief or treatment of local complications. Whereas
a lot of these patients undergo repetitive endoscopic interventions, surgical drainage results in better
long-term outcome. In patients with an inﬂammatory mass of the pancreatic head, surgical resection
procedures provide good short and long-term results, especially in terms of pain relief. This article
summarizes indications and potential of endoscopic/interventional and surgical therapy and gives an
overview of surgical techniques with special focus on organ-sparing procedures such as the duodenum-
preserving pancreatic head resection and its variants. Whereas exocrine and endocrine insufﬁciency may
progress, adequate surgical therapy can provide effective long-term pain relieve and improvement in the
quality of life in patients with CP.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Deﬁnition, epidemiology and etiology of
chronic pancreatitis
Chronic pancreatitis (CP) is a benign, inﬂammatory process of
the pancreas which leads to progressive and irreversible loss of
functional parenchyma and replacement with ﬁbrotic tissue and
ductal metaplasia.1 The ductal system displays stenoses and dila-
tations. CP can result in either an atrophy of the gland or in the
formation of an inﬂammatory mass, as often observed in European
series.2,3 Furthermore, CP can result in intraductal and/or paren-
chymal calciﬁcations. Clinically, the disease is characterized by
recurrent episodes of severe and uncontrollable upper abdominal
pain and by a loss of exocrine function (diarrhea, steatorrhea) and
endocrine function (diabetes mellitus). Histologically, CP is char-
acterized by inﬂammatory inﬁltration, acinar atrophy, formation of
metaplastic ductal lesions (Tubular complexes and Pancreatic
Intraepithelial Neoplasia), extended ﬁbrosis, and in some cases by
focal necrosis and cysts.4 Further neural hypertrophy and peri-
neural inﬂammation can frequently be observed and are the
correlate of neuropathic pain as discussed below.5: þ49 6221 565969.
de (J. Werner).
ciates Ltd. Published by Elsevier LtIncidence and prevalence of CP vary between continents and
countries. Most European studies show comparable incidence and
prevalence rates around 7 per 100,000 and 28 per 100,000,
respectively.6–8 The numbers reported from Asia are markedly
higher with a rapidly rising incidence up to 14 per 100,000.9,10 The
etiologic factors associated with CP are commonly summarized
using the TIGAR-O classiﬁcation: Toxic–metabolic (alcohol and
tobacco are the main reasons is Western countries associated with
up to 80–90% of cases), Idiopathic, Genetic (e.g. PRSS1, CFTR, or
SPINK1 gene mutations), Autoimmune, Recurrent and severe acute
pancreatitis or Obstructive (e.g. pancreas divisum, sphincter oddi
dysfunctions or neoplasms).11 The tropical CP is a common entity in
India, southern Africa and parts of South America and typically
affects younger patients; tropical CP is often classiﬁed as idiopathic
but may in fact have a mixed etiology, including nutritional,
metabolic and genetic factors.12
2. Pathophysiology and clinical presentation
The pathophysiology of CP remains a matter of debate. Over the
last decades several theories focusing on different etiologic and
pathomorphological aspects have been proposed (primary ductal
inﬂammation, ductal obstruction, oxidative stress, toxic–metabolic,d. All rights reserved.
O. Strobel et al. / International Journal of Surgery 7 (2009) 305–312306necrosis-ﬁbrosis). The SAPE (sentinel acute pancreatitis event)
hypothesis proposes a sentinel event of acute pancreatitis initiating
the inﬂammatory process which is then sustained by a combination
of the mechanisms mentioned above.13,14
Clinically the course of chronic pancreatitis is characterized by
recurrent episodes of upper abdominal pain, which represents the
most common indication for endoscopic and surgical intervention.
Additionally, patients may present with symptoms of endocrine
insufﬁciency (diabetes mellitus) and exocrine insufﬁciency (diar-
rhea, steatorrhea, malnutrition and weight loss). In the natural
course of CP, as the gland ‘‘burns out’’, episodes of pain may occur
less frequently and be less severe whereas endocrine and exocrine
insufﬁciency frequently increase.152.1. Local complications
Depending of the morphologic changes of the pancreas, patients
often have symptoms due to local complications (Fig. 1). The
inﬂammatory ductal changes and intraductal calculi (pan-
creatolithiasis) result in obstruction of the pancreatic duct itself,
which can result in multiple ductal stenoses and dilatations and
aggravate the process in the distal part of the gland. Additionally,
the intrapancreatic portion of the bile duct can be obstructed. An
inﬂammatory mass of the pancreatic head, as it is regularly
observed in European series,2 frequently results in obstruction of
the duodenum and compression and subsequent thrombosis of the
splenic, superior mesenteric or portal veins. Development of
pancreatic pseudocysts represents another local complication
which results in obstruction, abscess formation or in ascites/pleural
effusions in case of rupture. A rare but severe local complication of
chronic pancreatitis is vascular erosion presenting as gastrointes-
tinal hemorrhage or less frequently as intraabdominal bleeding.
Finally, CP is a risk factor for the development of pancreatic cancer;
Patients with CP have a 4-fold higher risk of cancer than individuals
without CP.16,17 Especially in the management of patients with an
‘‘inﬂammatory mass’’ this risk has to be taken in account.2.2. Pancreatic pain
Whereas all these local complications can per se cause upper
abdominal pain, the main mechanism of pain in CP is thought to be
a ‘‘parenchymal hypertension’’ due to ductal obstruction. This
mechanism is the rationale for endoscopic treatment as well asFig. 1. Local complications of chronic pancreatitis. Fibrosis and the inﬂammatory mass
can result in stenosis and prestenotic dilatation of the pancreatic duct, the common
bile duct and the duodenum. Intraductal concrements result in ductal obstruction.
Formation of pseudocysts result in local compression of neighboring structures. Not
shown: Parenchymal calciﬁcations and portal vein thrombosis.surgical drainage procedures. However, recent studies demonstrate
that to a large extent the pain in patients with chronic pancreatitis
is the consequence of neural alterations, namely a hypertrophy and
an inﬂammatory inﬁltration of peripheral intra- and peripancreatic
nerves.5 Thus, pancreatic neuropathic pain is the consequence of
pancreatic neuritis, which represents a common clinical feature of
CP and pancreatic cancer and appears to be associated with upre-
gulation of speciﬁc proteins.18,19 This pancreatic pain is frequently
observed in patients with an inﬂammatory mass in the pancreatic
head and can be effectively relieved by pancreatic head resection
(see Table 5).
3. Diagnostic work-up for chronic pancreatitis
A thorough medical history and physical examination is pivotal
for the diagnosis and adequate therapy of patients with CP
(Table 1). In the medical history, evaluation of etiologic factors
(especially alcohol) and of pancreatic pain is crucial to select
patients for the different therapeutic options as discussed below.
Besides routine parameters, laboratory data should include chole-
stasis parameters, and tumor markers for pancreatic adenocarci-
noma. In order to adequately inform patients about the course of
their disease and possible consequences of surgery (e.g. need of
insulin), the endocrine and exocrine function have to be evaluated.
Exocrine function test are often provided by gastroenterologists but
not required for surgical decision-making, except for patients with
uncertain diagnosis due to atypical clinical presentation.
For tailored therapy and especially for planning of surgical
therapy, imaging studies play a central role in the diagnostic work-
up of patients with CP. Most patients with CP ﬁrst consult general
practitioners and gastroenterologists. For the general practitioner
abdominal ultrasound is an effective screening method, which may
help to establish the diagnosis in patientswith a thickened pancreas
or head mass, a dilated duct, or pseudocysts. Gastroenterologists
frequently use endoscopic ultrasound, which is more sensitive and
speciﬁc than transabdominal ultrasound. Many patients undergo
multiple endoscopic retrograde cholangio-pancreatographies
(ERCP) fordiagnosis and therapeutic intervention. Thegold standard
of imaging for diagnosing CP and for the design of surgical therapy is
cross section imaging by contrast-enhanced computed tomography
(CT) andmagnetic resonance imaging (MRI). The superiority of CTor
MRI is still amatter of debate, but either imaging study is adequate ifTable 1
Preoperative diagnostic work-up in chronic pancreatitis.
Thorough medical history:
& Physical exam
- Etiologic factors: especially alcohol, smoking
- Symptoms: pain, signs of exocrine and
endocrine insufﬁciency, weight loss
- Previous treatment: analgesics, endoscopy
Laboratory work-up: - Routine laboratory parameters including liver
and cholestasis parameters
- Tumor markers (CEA, CA19-9)
Helpful but not mandatory: - Endocrine and exocrine function test (oral
glucose tolerance, fecal elastase etc.)
Imaging procedures: mandatory: - computed tomography (CT) or magnetic
resonance imaging (MRI)
Often provided by referring
gastroenterologist and helpful,
but not mandatory:
- Endoscopic retrograde cholangio-
pancreaticography (ERCP)a Endoscopic
ultrasound (EUS)
Not needed: - Preoperative tissue diagnosis
a Either ERCP or MRI with MRCP have to be performed for reliable evaluation of
the pancreatic duct.
Table 3
Interventional & endoscopic therapy: options and indications.
Interventional external drainage: Temporary treatment of pancreatic
abscess, infected pseudocyst
- often followed by deﬁnitive surgical
treatment
- if internal drainage is not possible
Interal drainage: Effective therapy of pseudocysts. No
RCTs with comparison to surgery
Endoscopic cystogastrostomy/
Endoscopic cytoduodenostomy
- if anatomically possible: less invasive
than surgery
- Problems with recurrence and
catheter dislocation
Endoscopic ductal drainage:
ePT Pancreas divisum, ‘‘sphincter of
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the MRI offers the additional possibility to evaluate the ductal
system by MR cholangiopancreatography. Only ERCP or MRCP
allows for evaluation according to the Cambridge-classiﬁcation,
which is at present still the only broadly accepted classiﬁcation-
system.20 The advantage of CT is the better visualization of paren-
chymal calciﬁcations. It has recently been proposed that positron
emission tomography (FDG-PET) is helpful to differentiate between
CP and pancreatic cancer.21 In fact, it is a difﬁcult task to rule out
cancer in a chronically inﬂamed pancreatic head. As indicated by
a recent review the indication for surgery for a pancreatic mass
should not be based on preoperative tissue diagnosis because of
frequent false negative results due to sampling problems.22 We
believe that patients with cancer as differential diagnosis should
undergo surgical exploration and resection.Oddi-dysfunction’’
ePTþ dilationþ stenting of
pancreatic duct
Proximal stenosis of pancreatic duct
ePTþ Lithotripsy & stone extraction Pancreatolithiasis
ePTþ bile duct stenting Bile duct stenosis
Caution: Poor outcome of endoscopic
treatment if
- distal stenosis of pancreatic duct
- parenchymal calciﬁcations
- no successful management after 1 year
RCT: Randomized-controlled trial, ePT: endoscopic papillotomy.4. Tailored therapy of chronic pancreatitis
4.1. Conservative therapy
Conservative treatment is the basis of any adequate managment
of CP and includes (i) reduction of etiologic risk factors, including
abstinence from alcohol and nicotine consumption, (ii) substitution
for exocrine and endocrine insufﬁciency and nutritional supple-
ments, as well as (iii) pain therapy according to theWHO-scheme23
(Table 2).
In autoimmune CP, a special entity which often presents as
diffuse gland enlargement but may present as focal lesion, immu-
nosuppression by corticosteroid treatment represents an effective
speciﬁc causal therapy resulting in both morphologic resolution
(imaging) and relief of symptoms. If autoimmune CP is suspected,
a corticosteroid-therapy should be tried and monitored clinically
and by radiologic imaging.244.2. Endoscopic and interventional treatment options
Many patients with CP require additional therapy for effective
pain relief or treatment of local complications. Most of these
patients are primarily referred to gastroenterologists and undergo
endoscopic treatment. Endoscopic treatment options and their
indications are summarized in Table 3. Pancreatic ductal obstruc-
tion by stenoses and/or calculi are the most frequent reasons forTable 2
Conservative and supportive treatment of chronic pancreatitis.
Causal therapy: Reduction of risk factors: abstinence from alcohol
and smoking
Special entity:
Suspected autoimmune
pancreatitis:
Corticosteroid treatment and re-evaluation!
Adjunct treatment: - Antioxidant therapy: promising results, needs
further evaluation
Pain therapy: - Reduction of etiologic factors
- Diet and treatment of exocrine insufﬁciency
- Analgesia according to the WHO-schemea
Therapy of exocrine
insufﬁciency:
- Diet
- Substitution with pancreatic enzymes
Therapy of endocrine
insufﬁciency:
- Diet
- Oral antidiabetics
- Insulin therapy
a Caution with opioids in patients with alcoholic chronic pancreatitis because of
risk of addiction.endoscopic therapy and the treatment modalities aim to decom-
press and drain the pancreatic ductal system. However, in almost all
patients endocopic treatments, such as stone extraction, dilations,
stenting etc. have to be repeated on a regular basis. In consequence,
the patients have to remain in endoscopic therapy and are
frequently re-hospitalized. Two recent randomized controlled trials
demonstrated the superiority of surgical vs. endoscopic therapy in
primary success rate, pain relief and quality of life in patients with
proximal duct obstruction.25,26 On the other hand a large multi-
centre study in 1018 patients reports a success rate of endocopic
therapy (multiple sessions) in 65% and necessity of surgery in only
24% of patients.27 A study in 61 patients with bile duct stenosis due
to CP reported a 1-year success-rate of 59% of endoscopic stenting
with stent replacement every three months, but failure of endo-
scopic therapy in the majority of cases with presence of calciﬁca-
tions (7.7% success rate).28 Moreover, 49% of patients without
successful therapy after one year ﬁnally underwent surgery.28 In
patients with symptomatic pseudocysts without ductal obstruc-
tion, endoscopic drainage procedures may be equally safe and
effective as surgical drainage and superior to external drainage, as
reported in a recent retrospective study.29 However, this remains to
be conﬁrmed in larger scale randomized trials.
These data allow the following recommendations concerning
endoscopic vs. surgical treatment of CP:
(i) Patients with proximal stenosis without calciﬁcations and
without inﬂammatory mass may be treated endoscopically. If
repetitive endoscopic treatment fails, the option of surgery has
to be evaluated.
(ii) In patients with distal obstruction, calciﬁcations or inﬂam-
matory mass surgery is superior to endoscopic treatment and
patients should undergo surgery early in the course of the
disease.
(iii) Pancreatic pseudocysts can be treated endoscopically. If
endoscopic treatment fails, a surgical drainage procedure
should be performed.
If endoscopic treatment does not result in effective pain relief,
patients should undergo surgical therapy early, because persistent
pancreatic pain may become pancreas-independent over time.
Table 4
Surgical therapy: techniques and indications.
Indications for surgery in chronic pancreatitis:
Intractable pain
Symptomatic local complications
Unsuccessful endoscopic management
Suspicion of malignancy
Surgical techniques Indications and recommendations
Pure drainage operations:
Cystojejunostomy (Fig. 2a) Surgical procedure of choice for isolated
pseudocysts
Caution: intraoperative frozen section to
exclude cystic neoplasm!
Laterolateral
pancreaticojejunostomy:Partington-
Rochelle-procedure (Fig. 2b)
Ductal dilation> 7 mm, without
inﬂammatory mass
Caudal drainage/Puestow-procedure: Rare indications, replaced by other
procedures
Resection procedures:
Pancreatic head resections (Fig. 3) Always include a ductal drainage
Procedures of choice if inﬂammatory mass
in the head of the pancreas
All techniques have comparable results
(see Table 5)
PD and ppPD (Fig. 3a) Procedure of choice in suspected
malignancy and in irreversible duodenal
stenosis
DPPHR techniques: Caution: intraoperative frozen section to
exclude malignancy!
DPPHR, Beger (Fig. 3b) Procedures of choice if inﬂammatory
mass in the head of the pancreas
DPPHR, Bern (Fig. 3d) Bern technically less difﬁcult than Beger
but equal long-term outcome
DPPHR, Frey (Fig. 3c) Patients with ductal obstruction in the
head and tail and a smaller inﬂammatory
mass in the head
V-shaped excision: Small duct disease (diameter of pancreatic
duct < 3 mm)
Pancreatic left resection Rare cases, e.g. isolated CP in the tail
(e.g. posttraumatic)
Rare cases of large pseudocysts in the tail
Segmental resection Rare cases, e.g. isolated ductal stenosis in
the body (e.g. posttraumatic) in patients
without diabetes.
Total pancreatectomy Rare cases with severe changes in the
entire pancreas and pre-existing IDDM
PD: pancreatoduodenectomy, ppPD: pylorus-preserving pancreatoduodenectomy,
DPPHR: duodenum-preserving pancreatic head resection, IDDM: insulin-dependent
diabetes mellitus.
Fig. 2. Drainage procedures in chronic pancreatitis. a) If the cyst wall is thick enough,
a pancreatic pseudocyst can be safely and effectively treated by drainage with a cysto-
jejunostomy and Roux-en-Y reconstruction. b) In rare patients with a dilation of the
pancreatic duct of> 7 mm without inﬂammatory mass, a laterolateral pan-
creatojejunostomy – Partington–Rochelle-procedure – may be performed.
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An overview about the common surgical procedures and the
indication for surgery are listed in Table 4. Pain remains the most
important and most frequent indication for surgery in CP, followed
by the local complications of CP as shown in Fig. 1. Suspicion of
malignancy is another important indication for surgery.
Surgical procedures in CP can be divided in drainage operations
(Fig. 2) and resections (Fig. 3).
4.3.1. Pure drainage procedures
In patients with isolated pancreatic pseudocysts, as frequently
observed in patients with a history of a severe episode of acute
pancreatitis, a drainage procedure in form of a cysto-jejunostomy
with Roux-en-y reconstruction (Fig. 2a) is still the surgical proce-
dure of choice. A pancreatic left resection may be a good alternative
in cases with large cysts in the pancreatic tail.
In patients with a ductal dilation without inﬂammatory mass in
the pancreatic head, a laterolateral pancreaticojejunostomy(Partington-Rochelle-procedure) represents an effective drainage
operation (Fig. 2b), which replaced the previously performed
caudal drainage procedures.
Whereas these ductal drainage operations have good primary
success rates,30,31 their long-term outcome is poor.32 Moreover,
these procedures are only promising if the duct is substantially
dilated (>7 mm) which is the case in only about 25% of cases.33 For
these reasons, pure drainage procedures have been replaced by
techniques which combine resection and drainage.
4.3.2. Resections
The vast majority of patients present with a ductal obstruction
located in the pancreatic head, frequently associated with an
inﬂammatory mass. In these patients pancreatic head resection is
the procedure of choice. The available techniques of pancreatic head
resection are shown in Fig. 3. The partial pancreatoduodenectomy
(Kausch-Whipple-procedure), in its classical or pylorus-preserving
variant, has been the procedure of choice for pancreatic head
resection in CP for many years.34,35 The duodenum-preserving
pancreatic head resections and its variants (Beger-procedure,36,37
Frey-procedure,38,39 and Bern-procedure40) represent less invasive,
organ-sparing techniqueswith equal long-term results (see Table 5).
In patients without circumscript mass in the pancreatic head
and small duct disease (diameter of the pancreatic duct <3 mm)
a V-shaped excision of the anterior aspect of the pancreas is a safe
approach with effective pain management.41
In the rare cases inwhich a patient presentswith segmental CP in
the pancreatic body or tail, e.g. due to posttraumatic ductal stenosis,
a middle segment pancreatectomy or a pancreatic left resection can
represent the best approach. Similarly, a total pancreatectomy may
be necessary in selected cases with severe inﬂammation involving
the entire pancreas and has to be evaluated especially in patients
with pre-existing insulin-dependent diabetes mellitus.42
4.4. Techniques of pancreatic head resection for chronic pancreatitis
4.4.1. Partial pancreatoduodenectomy: Kausch-Whipple-procedure
The extent of resection in the Kausch-Whipple pan-
creatoduodenectomy (PD) includes pancreatic head with duodenum
and the lower third of the stomach. PD was initially designed for
malignancies in the pancreatic head and associated with high
morbidity and mortality. With increasing safety the procedure has
also been used for patients with CP.43 With the pylorus-preserving
pancreatoduodenectomy (ppPD) a less invasive procedure for
Fig. 3. Techniques of pancreatic head resection for chronic pancreatitis. Resections are shown on the left, reconstructions on the right side. a) Partial pancreatoduodenectomy (here
shown as pylorus-preserving procedure). The pancreatic head is removed with the duodenum. The reconstruction is performed by a pancreatojejunostomy, hepaticojejunostomy
and a duodenojejunostomy (if pylorus-preserving). b) Duodenum-preserving pancreatic head resection: Beger-procedure. The pancreas is dissected on the level of the portal vein.
The pancreatic head is excavated and the duodenum is preserved with a thin layer of pancreatic tissue. If the bile duct is obstructed it can be opened and a internal anastomosis with
the excavated pancreatic head can be performed (not shown). The reconstruction is performed with two anastomoses, of the pancreatic tail remnant and of the excavated pancreatic
head with a Roux-en-Y jejunal loop. c) Duodenum-preserving pancreatic head resection: Frey-procedure. The Frey-procedure combines a circumscript excision in the pancreatic
head with longitudinal dissection of the pancreatic duct toward the tail. Reconstruction is performed with an anastomosis with a Roux-en-Y jejunal loop. Compared to the Beger-
procedure the extent of resection of the pancreatic head is smaller, however, reconstruction is easier as it only requires one anastomosis to the pancreas. d) Duodenum-preserving
pancreatic head resection: Bern modiﬁcation. The Bern modiﬁcation is a technical simpliﬁcation of the Beger-procedure. The extent of resection of the pancreatic head is
comparable to the Beger-procedure. However, the pancreas is not dissected on the level of the portal vein. Thus, reconstruction can be performed with one single anastomosis of the
pancreas with a Roux-en-Y jejunal loop. The bile duct can be opened and a internal anstomosis can be performed (as shown).
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preserved (Fig. 3a).44 In experienced hands PD and ppPD are safe and
effective procedures with an operative mortality of 2–5% and lasting
pain relief in about 80% of patients.33,34 Furthermore, PD provides the
beneﬁt of adequate resection of an unrecognized pancreatic adeno-
carcinoma, which may arise and presents a differential diagnosis in
some patients with CP.33 However, in contrast to patients with
pancreatic cancer, resection of the duodenum is not necessary in the
majority of patients with CP.
4.4.2. Duodenum-preserving pancreatic head resection: Procedure
according to Beger
Beger et al. introduced the duodenum-preserving pancreatic head
resection (DPPHR) as a less radical and organ-sparing procedure
designed speciﬁcally for patients with CP and an inﬂammatory mass
in the head of the pancreas.2,36,37,45 Similar to PD the pancreas is
divided at the level of the portal vein (Fig. 3b). However, in contrast to
PD, the pancreatic head is excavated with preservation of the
duodenum and a layer of pancreatic tissue. The reconstruction is
performed by two anastomoses with a jejunal loop to drain the
pancreatic remnantandtocoveranddrain thedefect in thepancreatic
head. During this procedure the commonbileduct canbeopenedand
drained with an internal anastomosis to treat bile duct obstruction.
The DPPHR has gained wide acceptance and has become the proce-
dure of choice for most patients with CP in Europe. However, maybe
because the technique is technically more demanding than PD, it is
not commonly used outside Europe.Table 5
Randomized controlled trials comparing techniques of pancreatic head resection for CP.
Author [ref.] (year) Technique- n results
RCTS comparing PD vs. DPPHR
Klempa55 (1995) Beger 21 Beger: shorter hosp
ppPD 22
Bu¨chler51 (1995) Beger 20 Beger: less impaire
ppPD 20
Follow-up:
Mu¨ller56 (1997) Beger 10 ppPD: more freque
ppPD 10
Follow-up:
Mu¨ller57 (2008) Beger 20 equal in pain relief
ppPD 20
Izbicki54 (1998) Frey 31 Frey: lower morbid
ppPD 30
Follow-up:
Strate59 (2008) Frey 23 equal in pain relief
ppPD 23
RCTs comparing different techniques of DPPHR
Izbicki52 (1995) Beger 20 comparable in pain
Frey 22
Follow-up:
Izbicki53 (1997) Beger 38 comparable in pain
Frey 36
Follow-up:
Strate58 (2005) Beger 34 comparable in pain
Frey 33
Ko¨ninger47 (2008) Beger 32 Bern: shorter oper
Bern 33
RCT: Randomized-controlled trial, PD: pancreatoduodenectomy, ppPD: pylorus-preservi
tion, QoL: Quality of life.4.4.3. Duodenum-preserving pancreatic head resection: Procedure
according to Frey
Frey et al. developed a modiﬁcation of DPPHR which represents
a hybrid technique between the Beger- and Partington-Rochelle
procedures.38,39,46 Compared to the Beger-procedure the resection
in the pancreatic head in the Frey-modiﬁcation is smaller and
combined with a laterolateral pancreaticojejunostomy to drain the
entire pancreatic duct towards the tail (Fig. 3c). In contrast to the
Beger-procedure reconstruction can be performed with one single
anastomosis. This procedure is not suitable in patients with a large
inﬂammatory mass in the pancreas without stenosis of the left-
sided pancreatic duct, as often observed in the European series.
However, it appears advantageous in patients with less severe
inﬂammation in the head combined with an obstruction in the left-
sided pancreatic duct.
4.4.4. Duodenum-preserving pancreatic head resection: Bern
modiﬁcation
The Bern modiﬁcation of the DPPHR represents a technical
simpliﬁcation of the Beger-procedure with equal outcome.40,47–49
The excavation of the pancreatic head can be performed with
identical extent compared to the Berger-procedure (Fig. 3d).
However, in contrast to the Beger-procedure the pancreas is not
divided at the level of the portal vein,which is often difﬁcult because
of inﬂammation and portal hypertension. The reconstruction can be
performedbyone single anastomosis betweena jejunal loop and the
continuous pancreatic resection rim.40 As in the Beger-procedure,ital stay, less exocrine insufﬁciency, less need of analgesics
d glucose metabolism, higher gain of weight, more frequent pain relief
nt delayed gastric empting, more frequent pathologic secretion of enteral hormons
, exocrine & endocrine function equal in QoL
ity, better QoL better professional rehabilitation equal in pain relief
and QoL, equal in exocrine & endocrine function
relief, QoL, exocrine & endocrine function, management of local complications
relief, QoL, professional rehabilitation, exocrine & endocrine function
relief, QoL, exocrine & endocrine function.
ative time & hospital stay comparable in QoL
ng pancreatoduodenectomy, DPPHR: duodenum-preserving pancreatic head resec-
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tomosis. The Bern-modiﬁcation of DPPHR appears ideal for patients
with an inﬂammatory mass and without stenosis in the left-sided
duct. Adequate drainage of the pancreatic duct has to be veriﬁed by
probing. If a stenosis is discovered, the resection can be extended
towards the left similar to the Frey/Partingtin-Rochelle procedures
until adequate drainage is achieved. However, in our series this is
necessary in only 2–3% of cases.49
Independent of the technique of DPPHR, an intraoperative
frozen section has to be obtained to rule out pancreatic adenocar-
cinoma. If the frozen section is suspicious for malignancy or if
a cancer is suspected already preoperatively, a PD represents the
oncologically adequate approach.
4.5. PD and DPPHR in chronic pancreatitis: Results and evidence
Irrespective of the technique, if carried out by experienced
hands pancreatic head resection is a safe and effective therapy with
good short- and long-term results in patients with CP and an
inﬂammatory mass in the head of the pancreas.35,36,39,45,48–50
The above-mentioned techniques of pancreatic head resection
were compared in several randomized-controlled trials (RCTs)
(Table 5),47,51–59 in which their safety and efﬁcacy was conﬁrmed.
The RCTs comparing PD and DPPHR51,54–57,59 as well as a recent
metaanalysis60 demonstrate comparable mortality and efﬁcacy in
terms of pain relief as well as endocrine insufﬁciency; however,
the less invasive DPPHR was superior in hospital stay, exocrine
insufﬁciency, weight gain and quality of life in medium-term
follow-up. In even more recent studies with long-term follow-up
these metabolic advantages appear to be lost over time and long-
term results of PD and DPPHR are equal in terms of pain
management and quality of life as well as endocrine and exocrine
function (compare results reported in the initial trials and the
latest follow-ups in Table 5).51,54–57,59 Of interest, the resection
techniques remain effective in terms of pain relief and quality of
life but cannot stop the progress of exocrine and endocrine
insufﬁciency on the long-term.48,59 One explanation may be that
resection effectively treats the obstruction and hypertension, but
does not completely stop continued cellular damage and paren-
chymal loss.33 Certainly these observations stress the importance
of continued conservative treatment by with reduction of etiologic
factors, substitution for exocrine and endocrine insufﬁciency and
probably antioxidant therapy.61
The RCTs comparing different techniques of DPPHR demonstrate
equal outcome in both pain control/quality of life and metabolic
parameters after Beger vs. Frey and Beger vs. Bern technique
(Table 5).47,52,53,58 However, with equal outcome, the Bern modiﬁ-
cation of DPPHR represents a technically simpler alternative, as
reﬂected by a signiﬁcantly (by 46 minutes) shorter operative time
as well as a signiﬁcantly shorter hospital stay (11 vs. 15 days).47
Recent reports conﬁrm that the Bern modiﬁcation of DPPHR can be
performed without severe complications or mortality in smaller
series.62,63 Thus, the Bern technique represents a modiﬁcation of
DPPHR which may ﬁnd broader acceptance due to technical and
economic advantages.
5. Conclusions
The adequate therapy of chronic pancreatitis is adjusted to the
symptoms of the patient, the stage of the disease and the
morphology of the pathological changes of the pancreas. Conser-
vative therapy is the basis of treatment in all patients and has to
accompany both interventional and surgical therapy. Endoscopic
therapy appears to be effective for internal drainage of pseudocystsand in proximal ductal stenoses in patients without calciﬁcations.
However, endoscopic therapy requires frequent reinterventions
and if it is not sufﬁciently effective after one year, the patient should
be referred to surgery. The surgical technique has to be adjusted to
the pathomorphological changes of the pancreas. This article gives
an overview of the most common surgical options for therapy of CP
and their typical indications. Recent data proposes that regional
differences in the surgical strategy and preferred surgical tech-
niques for pancreatic head resection may in fact be based on
differences in the anatomic pathology between patient series.3 For
patients with CP and an inﬂammatory mass in the head of the
pancreas the DPPHR is less invasive than a PD with comparable
long-term results and should thus be considered as treatment of
choice. The Bern modiﬁcation of DPPHR represents a technical
variation which is equally effective but technically less demanding.
Whereas surgical therapy provides effective long-term pain-relief
and improvement of quality of life, it does not stop a decrease in
both endocrine and exocrine function. Thus, endocrine and
exocrine function should currently not be considered to deﬁne
a successful therapy in CP. Instead, strategies for improvement or
maintenance of endocrine and exocrine function remain an
important ﬁeld of research.
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